GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes.
Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, VA 22042, USA; Johns Hopkins University School of Medicine, Baltimore, MD, USA; Duke University School of Medicine, Durham, NC, USA. Electronic address: paul.gurbel@inova.org.
Paul A
PA
Gurbel
Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, VA 22042, USA.
Udaya S
US
Tantry
D054058:Acute Coronary Syndrome; D001241:Aspirin / Q000627:therapeutic use; D005343:Fibrinolytic Agents; D006801:Humans; D010975:Platelet Aggregation Inhibitors; D000069552:Rivaroxaban / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D000069552:Rivaroxaban; D001241:Aspirin